- Home
- FSM vs APGE Comparison
FSM vs APGE Comparison
Compare FSM & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSM
- APGE
- Stock Information
- Founded
- FSM 1990
- APGE 2022
- Country
- FSM Canada
- APGE United States
- Employees
- FSM N/A
- APGE N/A
- Industry
- FSM Precious Metals
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FSM Basic Materials
- APGE Health Care
- Exchange
- FSM Nasdaq
- APGE Nasdaq
- Market Cap
- FSM 2.3B
- APGE 2.0B
- IPO Year
- FSM N/A
- APGE 2023
- Fundamental
- Price
- FSM $7.72
- APGE $36.37
- Analyst Decision
- FSM Hold
- APGE Strong Buy
- Analyst Count
- FSM 1
- APGE 5
- Target Price
- FSM $8.00
- APGE $95.40
- AVG Volume (30 Days)
- FSM 13.0M
- APGE 482.6K
- Earning Date
- FSM 08-06-2025
- APGE 08-11-2025
- Dividend Yield
- FSM N/A
- APGE N/A
- EPS Growth
- FSM 7355.92
- APGE N/A
- EPS
- FSM 0.50
- APGE N/A
- Revenue
- FSM $1,187,211,000.00
- APGE N/A
- Revenue This Year
- FSM N/A
- APGE N/A
- Revenue Next Year
- FSM N/A
- APGE N/A
- P/E Ratio
- FSM $15.01
- APGE N/A
- Revenue Growth
- FSM 46.81
- APGE N/A
- 52 Week Low
- FSM $4.13
- APGE $26.20
- 52 Week High
- FSM $7.75
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- FSM 63.26
- APGE 44.89
- Support Level
- FSM $7.32
- APGE $36.64
- Resistance Level
- FSM $7.66
- APGE $38.46
- Average True Range (ATR)
- FSM 0.28
- APGE 1.57
- MACD
- FSM 0.05
- APGE 0.11
- Stochastic Oscillator
- FSM 97.07
- APGE 41.64
About FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.